{{Rsnum
|rsid=7494275
|Gene=RPL13AP3
|Chromosome=14
|position=55765082
|Orientation=plus
|GMAF=0.1428
|Gene_s=RPL13AP3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 32.1 | 46.3 | 21.6
| JPT | 27.7 | 48.2 | 24.1
| YRI | 93.8 | 6.2 | 0.0
| ASW | 94.7 | 5.3 | 0.0
| CHB | 32.1 | 46.3 | 21.6
| CHD | 25.9 | 54.6 | 19.4
| GIH | 77.2 | 22.8 | 0.0
| LWK | 99.1 | 0.0 | 0.9
| MEX | 63.8 | 29.3 | 6.9
| MKK | 93.6 | 5.8 | 0.6
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=C
  |Pval=9E-6
  |OR=1.73
  |ORtxt=[1.232-2.433]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}